Host defense against infection in the airways

Respiratory Infections

Volumn , Issue , 2016, Pages 17-28

  Hiemstra, Pieter S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84977617739     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (47)

1. Corrin B, Nicholson A. Pathology of the Lungs. 2nd ed. New York, NY: Churchill Liv ingstone, 2006.
2. Chang MM, Shih L, Wu R. Pulmonary epithelium: cell types and functions. In: Proud D, ed. The Pulmonary Epithelium in Health and Disease. Chichester, UK: Wiley, 2008:1-14.
3. Wine JJ, Joo NS. Submucosal glands and airway defense. Proc Am Thorac Soc 2004; 1(1): 47-53.
4. Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol 2008; 70(1):459-486.
5. Thai P, Loukoianov A, Wachi S, et al. Regulation of airway mucin gene expression. Annu Rev Physiol 2008; 70:405-429.
6. Martin TR, Frevert CW. Innate immunity in the lungs. Proc Am Thorac Soc 2005; 2(5):403-411.
7. Zaas AK, Schwartz DA. Innate immunity and the lung: defense at the interface between host and environment. Trends Cardiovasc Med 2005; 15(6):195-202.
8. Suzuki T, Chow CW, Downey GP. Role of innate immune cells and their products in lung immunopathology. Int J Biochem Cell Biol 2008; 40(6-7):1348-1361.
9. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124(4): 783-801.
10. Sabroe I, Parker LC, Dower SK, et al. The role of TLR activation in inflammation. J Pathol 2008; 214(2):126-135.
11. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81(1):1-5.
12. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25(2):187-191.
13. Lee MS, Kim YJ. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007; 76:447-480.
14. Thepen T, Van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 1989; 170(2):499-509.
15. Blumenthal RL, Campbell DE, Hwang P, et al. Human alveolar macrophages induce func tional inactivation in antigen-specific CD4 T cells. J Allergy Clin Immunol 2001; 107(2): 258-264.
16. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3(1):23-35.
17. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73(2):209-212.
18. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macro phage activation and polarization. Trends Immunol 2004; 25(12):677-686.
19. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007; 25:381-418.
20. Novak N, Bieber T. 2. Dendritic cells as regulators of immunity and tolerance. J Allergy Clin Immunol 2008; 121(2 suppl):S370-S374.
21. Holt PG, Strickland DH, Wikstrom ME, et al. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008; 8(2):142-152.
22. Jahnsen FL, Strickland DH, Thomas JA, et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J Immunol 2006; 177(9):5861-5867.
23. Cao W, Liu YJ. Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 2007; 19(1):24-30.
24. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006; 6(3):173-182.
25. Borregaard N, Sorensen OE, Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007; 28(8):340-345.
26. Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Micro 2007; 5(8):577-582.
27. Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38(5):709-750.
28. Galli SJ, Kalesnikoff J, Grimbaldeston MA, et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23:749-786.
29. Strieter RM, Belperio JA, Keane MP. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 2003; 16(3):193-198.
30. Garcia-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006; 312(5775):879-882.
31. Rogan MP, Geraghty P, Greene CM, et al. Antimicrobial proteins and polypeptides in pul monary innate defence. Respir Res 2006; 7:29.
32. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005; 17(4):359-365.
33. Ganz T. Antimicrobial polypeptides. J Leukoc Biol 2004; 75(1):34-38.
34. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respi ratory pathogens. Eur Respir J 2004; 23:327-733.
35. Hiemstra PS. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp Lung Res 2007; 33(10):537-542.
36. Hiemstra PS. Epithelial antimicrobial molecules. In: Proud D, ed. The Pulmonary Epithelium in Health and Disease. Chichester, UK: Wiley, 2008:187-200.
37. Wright JR. The "wisdom" of lung surfactant: balancing host defense and surface tension-reducing functions. Am J Physiol Lung Cell Mol Physiol 2006; 291(5):L847-L850.
38. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284(5418):1318.
39. Singh PK, Parsek MR, Greenberg EP, et al. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417(6888):552-555.
40. Overhage J, Campisano A, Bains M, et al. The human host defence peptide LL-37 prevents bacterial biofilm formation. Infect Immun 2008; 76(9):4176-4182.
41. Moskwa P, Lorentzen D, Excoffon KJDA, et al. A novel host defense system of airways is defective in cystic fibrosis. Am J Respir Crit Care Med 2007; 175(2):174-183.
42. van der Vliet A. NADPH oxidases in lung biology and pathology: host defense enzymes, and more. Free Radic Biol Med 2008; 44(6):938-955.
43. Ricciardolo FL, Sterk PJ, Gaston B, et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84(3):731-765.
44. Lefrancois L, Puddington L. Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annu Rev Immunol 2006; 24:681-704.
45. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8(7):523-532.
46. Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: novel concepts in the patho genesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005; 116(5): 961-968.
47. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cyto kines in inflammation. Immunity 2008; 28(4):454-467.